Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref‐1 in thyroid cancer cells: A novel tumorigenic pathway

Nucleotide receptors signaling affects cell proliferation, with possible implications on tumorigenic processes. However, molecular targets and action mechanisms of the extracellular nucleotides are still poorly elucidated. We have previously shown in ARO cells that APE1/Ref‐1, a transcriptional coactivator responsible for the maintenance of the cellular proliferative rate, is functionally controlled by P2‐mediated signaling. Here, we demonstrate that extracellular ATP has a mitogenic effect on ARO cells, increasing ERK phosphorylation, AP1 activation, and cyclin D1 expression. Using the ATP/ADPase apyrase and the P2 receptor antagonist suramin, we show that the extracellular ATP, physiologically released by ARO cells, exerts mitogenic effects. A differential proteomic approach was used to identify molecular events associated with the ATP‐induced cell proliferation. Among other proteins, Hsp90 was found upregulated upon ATP stimulation. Pretreatment with suramin completely blocked the ATP‐induced Hsp90 activation, confirming the involvement of cell‐surface P2 nucleotide receptors in the ATP‐mediated activation of ARO cells. Treatment of proliferating ARO cells with suramin and apyrase significantly reduced the intracellular levels of Hsp90, suggesting an autocrine/paracrine mechanism of control on Hsp90 expression by extracellular ATP. The influence of Hsp90 on ATP‐induced cell proliferation was also demonstrated by its specific inhibition with 17‐AAG. The molecular pathway by which ATP stimulates cell proliferation was further investigated by siRNA strategies showing that Hsp90 is a target of APE1/Ref‐1 functional activation. Stimulation of ARO cells with specific nucleotide receptors agonists evidenced a major involvement of P2Y1 and P2Y2 receptors in controlling the Hsp90 activation. Accordingly, these two receptors resulted significantly upregulated in sample biopsies from different thyroid tumors. J. Cell. Physiol. 209: 44–55, 2006. © 2006 Wiley‐Liss, Inc.

[1]  G Burnstock,et al.  Is there a basis for distinguishing two types of P2-purinoceptor? , 1985, General pharmacology.

[2]  Peter E. M. Butler,et al.  P2Y purinergic receptors regulate the growth of human melanomas. , 2005, Cancer letters.

[3]  P. Ping,et al.  PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. , 1999, The American journal of physiology.

[4]  G. Burnstock,et al.  Regulation of bone resorption and formation by purines and pyrimidines. , 2003, Trends in pharmacological sciences.

[5]  G. Tell,et al.  The intracellular localization of APE1/Ref-1: more than a passive phenomenon? , 2005, Antioxidants & redox signaling.

[6]  Z. Naito,et al.  Expression of hsp90 and cyclin D1 in human breast cancer. , 1999, Cancer letters.

[7]  J. Hescheler,et al.  Activation of p90RSK and growth stimulation of multicellular tumor spheroids are dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  L. Oberley,et al.  Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells. , 2003, American journal of physiology. Heart and circulatory physiology.

[9]  D. Erlinge,et al.  Tyrphostin inhibition of ATP‐stimulated DNA synthesis, cell proliferation and Fos‐protein expression in vascular smooth muscle cells , 1996, British journal of pharmacology.

[10]  Vijaya R Arjunan,et al.  Extracellular ATP activates c‐jun N‐terminal kinase signaling and cell cycle progression in hepatocytes , 2004, Hepatology.

[11]  W. Fang,et al.  ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. , 2004, Cancer letters.

[12]  F. Di Virgilio,et al.  Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. , 2005, Endocrinology.

[13]  J. Simon,et al.  Mechanisms of P2 receptor‐evoked DNA synthesis in thyroid FRTL‐5 cells , 2001, Journal of cellular physiology.

[14]  R. Hipskind,et al.  Signaling in Human Osteoblasts by Extracellular Nucleotides , 1999, The Journal of Biological Chemistry.

[15]  R. Rodnight,et al.  ERK, PKC and PI3K/Akt Pathways Mediate Extracellular ATP and Adenosine-Induced Proliferation of U138-MG Human Glioma Cell Line , 2005, Oncology.

[16]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[17]  G. Burnstock,et al.  P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[18]  D. Erlinge Extracellular ATP: a growth factor for vascular smooth muscle cells. , 1998, General pharmacology.

[19]  I. Novak ATP as a signaling molecule: the exocrine focus. , 2003, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[20]  M. Gulisano,et al.  Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP , 2005, Nucleic acids research.

[21]  Andrea Scaloni,et al.  Activation of human T lymphocytes under conditions similar to those that occur during exposure to microgravity: A proteomics study , 2005, Proteomics.

[22]  G. Tell,et al.  Extracellular ATP stimulates the early growth response protein 1 (Egr-1) via a protein kinase C-dependent pathway in the human osteoblastic HOBIT cell line. , 2003, The Biochemical journal.

[23]  B. Chait,et al.  ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. , 2000, Analytical chemistry.

[24]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[25]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[26]  Q. Duh,et al.  The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines. , 2003, The Journal of clinical endocrinology and metabolism.

[27]  S. Jhiang,et al.  Inhibition of Heat Shock Protein 90, a Novel RET/PTC1-associated Protein, Increases Radioiodide Accumulation in Thyroid Cells* , 2004, Journal of Biological Chemistry.

[28]  Vivek Mittal,et al.  Improving the efficiency of RNA interference in mammals , 2004, Nature Reviews Genetics.

[29]  Nancy Y. Ip,et al.  ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF , 1991, Cell.

[30]  David J. Chen,et al.  Two essential but distinct functions of the mammalian abasic endonuclease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[32]  L. Heppel,et al.  Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Insel,et al.  Cellular Release of and Response to ATP as Key Determinants of the Set-Point of Signal Transduction Pathways* , 2000, The Journal of Biological Chemistry.

[34]  C. Zuiani,et al.  Proteomic evaluation of core biopsy specimens from breast lesions. , 2004, Cancer letters.

[35]  B. Demple,et al.  A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. , 2005, Molecular cell.

[36]  G. Burnstock,et al.  Purinoceptors: are there families of P2X and P2Y purinoceptors? , 1994, Pharmacology & therapeutics.

[37]  M. Romanello,et al.  Mechanically induced ATP release from human osteoblastic cells. , 2001, Biochemical and biophysical research communications.

[38]  A. Kamal,et al.  Therapeutic and diagnostic implications of Hsp90 activation , 2004, Trends in Molecular Medicine.

[39]  B. Dugué,et al.  Purinergic agonist ATP is a comitogen in thyroid FRTL‐5 cells , 1996, Journal of cellular physiology.

[40]  K. Suzuki,et al.  Ras‐dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. , 1994, The EMBO journal.

[41]  F. Sundler,et al.  Presence and influence of cholinergic nerves in the human thyroid. , 1979, The Journal of clinical endocrinology and metabolism.

[42]  S. Ohtaki,et al.  Extracellular ATP-induced production of hydrogen peroxide in porcine thyroid cells. , 1990, The Journal of endocrinology.

[43]  Richard J. Lee,et al.  Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis* , 1999, The Journal of Biological Chemistry.

[44]  M. Saji,et al.  17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. , 2004, The Journal of clinical endocrinology and metabolism.

[45]  M. Ferrarini,et al.  Unusual expression and localization of heat‐shock proteins in human tumor cells , 1992, International journal of cancer.

[46]  Chih‐Chung Lin,et al.  P2Y2 receptor‐mediated proliferation of C6 glioma cells via activation of Ras/Raf/MEK/MAPK pathway , 2000, British journal of pharmacology.

[47]  L. Mahadevan,et al.  Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.

[48]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[49]  G. Burnstock,et al.  Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. , 2003, The Journal of investigative dermatology.

[50]  A. Vertegaal Protein kinase C-$alpha; is an upstream activator of the I$kappa;B kinase complex in the TPA signal transduction pathway to NF-$kappa;B in U2OS cells , 2000 .

[51]  L. Heppel,et al.  Extracellular ATP is a mitogen for 3 T 3 , 3 T 6 , and A 431 cells and acts synergistically with other growth factors ( purinoceptor / competence factor / ectoenzymes ) , 2022 .

[52]  G. Burnstock,et al.  P 2 X and P 2 Y purinergic receptors on human intestinal epithelial carcinoma cells : effects of extracellular nucleotides on apoptosis and cell proliferation , 2005 .

[53]  J. Neary,et al.  Trophic Roles of Purines and Pyrimidines , 2001 .

[54]  A. Scaloni,et al.  A differential proteomic approach to identify proteins associated with thyroid cell transformation. , 2005, Journal of molecular endocrinology.

[55]  G. Burnstock Purinergic Signaling and Vascular Cell Proliferation and Death , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[56]  A. Muscella,et al.  Disturbances in purinergic [Ca2+]i signaling pathways in a transformed rat thyroid cell line. , 2003, Cell calcium.